JP2017095393A - Foamy skin cleanser - Google Patents
Foamy skin cleanser Download PDFInfo
- Publication number
- JP2017095393A JP2017095393A JP2015228932A JP2015228932A JP2017095393A JP 2017095393 A JP2017095393 A JP 2017095393A JP 2015228932 A JP2015228932 A JP 2015228932A JP 2015228932 A JP2015228932 A JP 2015228932A JP 2017095393 A JP2017095393 A JP 2017095393A
- Authority
- JP
- Japan
- Prior art keywords
- component
- foam
- fatty acid
- stock solution
- mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 54
- 239000000194 fatty acid Substances 0.000 claims abstract description 54
- 229930195729 fatty acid Natural products 0.000 claims abstract description 54
- -1 phosphate ester salt Chemical class 0.000 claims abstract description 47
- 239000011550 stock solution Substances 0.000 claims abstract description 39
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 29
- 239000003380 propellant Substances 0.000 claims abstract description 22
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000443 aerosol Substances 0.000 claims abstract description 16
- 150000003839 salts Chemical class 0.000 claims abstract description 16
- 239000003915 liquefied petroleum gas Substances 0.000 claims abstract description 12
- 239000001569 carbon dioxide Substances 0.000 claims abstract description 9
- 229910002092 carbon dioxide Inorganic materials 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 8
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract description 8
- 239000010452 phosphate Substances 0.000 claims abstract description 8
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 8
- 239000004359 castor oil Substances 0.000 claims abstract description 7
- 235000019438 castor oil Nutrition 0.000 claims abstract description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims abstract description 7
- 229920001223 polyethylene glycol Polymers 0.000 claims description 27
- 239000002202 Polyethylene glycol Substances 0.000 claims description 26
- 229930195712 glutamate Natural products 0.000 claims description 8
- 239000003599 detergent Substances 0.000 claims description 6
- 239000006260 foam Substances 0.000 abstract description 52
- 239000007789 gas Substances 0.000 abstract description 7
- 239000002253 acid Substances 0.000 abstract description 6
- 239000000243 solution Substances 0.000 abstract description 4
- 238000011049 filling Methods 0.000 abstract description 2
- 238000007599 discharging Methods 0.000 abstract 1
- 238000011156 evaluation Methods 0.000 description 33
- 239000000463 material Substances 0.000 description 16
- 238000001556 precipitation Methods 0.000 description 16
- 239000013078 crystal Substances 0.000 description 14
- 230000002708 enhancing effect Effects 0.000 description 13
- 206010040880 Skin irritation Diseases 0.000 description 12
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 12
- 230000036556 skin irritation Effects 0.000 description 12
- 231100000475 skin irritation Toxicity 0.000 description 12
- 125000004432 carbon atom Chemical group C* 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 125000002252 acyl group Chemical group 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000001282 iso-butane Substances 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 5
- 239000003240 coconut oil Substances 0.000 description 5
- 235000019864 coconut oil Nutrition 0.000 description 5
- 230000007794 irritation Effects 0.000 description 5
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- YVIGPQSYEAOLAD-UHFFFAOYSA-L disodium;dodecyl phosphate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOP([O-])([O-])=O YVIGPQSYEAOLAD-UHFFFAOYSA-L 0.000 description 3
- 150000002169 ethanolamines Chemical class 0.000 description 3
- 238000005187 foaming Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 3
- 210000004761 scalp Anatomy 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010006784 Burning sensation Diseases 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- QWTDNUCVQCZILF-UHFFFAOYSA-N isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 2
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920000223 polyglycerol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 229940079781 sodium cocoyl glutamate Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 229940083957 1,2-butanediol Drugs 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- LRZBIPQJHILPJI-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-(2,3-dihydroxypropyl)octadecanoate Chemical compound CCCCCCCCCCCCCCCCC(CC(O)CO)C(=O)OCC(O)CO LRZBIPQJHILPJI-UHFFFAOYSA-N 0.000 description 1
- ACCAIGJKLCJFHP-UQKRIMTDSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;(2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O ACCAIGJKLCJFHP-UQKRIMTDSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- ZVUNTIMPQCQCAQ-UHFFFAOYSA-N 2-dodecanoyloxyethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCC ZVUNTIMPQCQCAQ-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- SBFLFRSXNYZPEH-YMKFFAQDSA-N [(2r)-3-[(2s)-3-[(2s)-2-butanoyloxy-3-[(2r)-2-hydroxy-3-[(2s)-3-[(2r)-3-hydroxy-2-pentanoyloxypropoxy]-2-propanoyloxypropoxy]propoxy]propoxy]-2-hydroxypropoxy]-2-hydroxypropyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)COC[C@H](O)COC[C@H](OC(=O)CCC)COC[C@H](O)COC[C@H](OC(=O)CC)COC[C@@H](CO)OC(=O)CCCC SBFLFRSXNYZPEH-YMKFFAQDSA-N 0.000 description 1
- BKZCZANSHGDPSH-KTKRTIGZSA-N [3-(2,3-dihydroxypropoxy)-2-hydroxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)COCC(O)CO BKZCZANSHGDPSH-KTKRTIGZSA-N 0.000 description 1
- SJLAFUFWXUJDDR-KTKRTIGZSA-N [3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]-2-hydroxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)COCC(O)COCC(O)CO SJLAFUFWXUJDDR-KTKRTIGZSA-N 0.000 description 1
- NPTLAYTZMHJJDP-KTKRTIGZSA-N [3-[3-[3-[3-[3-[3-[3-[3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)CO NPTLAYTZMHJJDP-KTKRTIGZSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- XQGDCUULTKHHEM-UHFFFAOYSA-N butane-1,3-diol Chemical compound CC(O)CCO.CC(O)CCO XQGDCUULTKHHEM-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000010624 camphor oil Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- YSRSBDQINUMTIF-UHFFFAOYSA-N decane-1,2-diol Chemical compound CCCCCCCCC(O)CO YSRSBDQINUMTIF-UHFFFAOYSA-N 0.000 description 1
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 229940031766 diethanolamine cetyl phosphate Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- AFABGHUZZDYHJO-UHFFFAOYSA-N dimethyl butane Natural products CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- JOLYVEWZEPKDIJ-UTLKBRERSA-L dipotassium;(2s)-2-(dodecanoylamino)pentanedioate Chemical compound [K+].[K+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O JOLYVEWZEPKDIJ-UTLKBRERSA-L 0.000 description 1
- WDRWZVWLVBXVOI-QTNFYWBSSA-L dipotassium;(2s)-2-aminopentanedioate Chemical compound [K+].[K+].[O-]C(=O)[C@@H](N)CCC([O-])=O WDRWZVWLVBXVOI-QTNFYWBSSA-L 0.000 description 1
- GWTCIAGIKURVBJ-UHFFFAOYSA-L dipotassium;dodecyl phosphate Chemical compound [K+].[K+].CCCCCCCCCCCCOP([O-])([O-])=O GWTCIAGIKURVBJ-UHFFFAOYSA-L 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229910001651 emery Inorganic materials 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- GKKMCECQQIKAHA-UHFFFAOYSA-N hexadecyl dihydrogen phosphate;2-(2-hydroxyethylamino)ethanol Chemical compound OCCNCCO.CCCCCCCCCCCCCCCCOP(O)(O)=O GKKMCECQQIKAHA-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002669 linoleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- NJTGANWAUPEOAX-UHFFFAOYSA-N molport-023-220-454 Chemical compound OCC(O)CO.OCC(O)CO NJTGANWAUPEOAX-UHFFFAOYSA-N 0.000 description 1
- 235000013919 monopotassium glutamate Nutrition 0.000 description 1
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000003209 petroleum derivative Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229940082006 potassium cocoyl glutamate Drugs 0.000 description 1
- 229940099874 potassium lauroyl glutamate Drugs 0.000 description 1
- 229940033623 potassium lauryl phosphate Drugs 0.000 description 1
- KCQOKZAQSWTPIL-BDQAORGHSA-M potassium;(4s)-5-hydroxy-4-(octadecanoylamino)-5-oxopentanoate Chemical compound [H+].[K+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O KCQOKZAQSWTPIL-BDQAORGHSA-M 0.000 description 1
- KYLDDUZJZSKJER-NTISSMGPSA-M potassium;(4s)-5-hydroxy-5-oxo-4-(tetradecanoylamino)pentanoate Chemical compound [H+].[K+].CCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O KYLDDUZJZSKJER-NTISSMGPSA-M 0.000 description 1
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000013441 quality evaluation Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 229940045944 sodium lauroyl glutamate Drugs 0.000 description 1
- 229940077092 sodium myristoyl glutamate Drugs 0.000 description 1
- 229940045898 sodium stearoyl glutamate Drugs 0.000 description 1
- IWIUXJGIDSGWDN-UQKRIMTDSA-M sodium;(2s)-2-(dodecanoylamino)pentanedioate;hydron Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O IWIUXJGIDSGWDN-UQKRIMTDSA-M 0.000 description 1
- FCBUGCHAVCFTHW-NTISSMGPSA-N sodium;(2s)-2-(tetradecanoylamino)pentanedioic acid Chemical compound [Na].CCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O FCBUGCHAVCFTHW-NTISSMGPSA-N 0.000 description 1
- KDHFCTLPQJQDQI-BDQAORGHSA-M sodium;(4s)-4-amino-5-octadecanoyloxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC([O-])=O KDHFCTLPQJQDQI-BDQAORGHSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- VUYXVWGKCKTUMF-UHFFFAOYSA-N tetratriacontaethylene glycol monomethyl ether Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO VUYXVWGKCKTUMF-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- SCRSFLUHMDMRFP-UHFFFAOYSA-N trimethyl-(methyl-octyl-trimethylsilyloxysilyl)oxysilane Chemical compound CCCCCCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C SCRSFLUHMDMRFP-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Abstract
Description
本発明は、フォーム状皮膚洗浄料に関する。 The present invention relates to a foam skin cleanser.
従来、種々のエアゾール製品があるが、エアゾール容器から吐出される際に泡を形成するフォーム状皮膚洗浄料は、顔、手、身体、頭皮や毛髪用の洗浄料等に用いられている。これらのフォーム状皮膚洗浄料は、原液と噴射剤とがエアゾール容器に充填されており、原液には洗浄剤組成物として、例えば、アニオン性界面活性剤が含有されており、噴射剤としては液化石油ガス(LPG)等が用いられている。 Conventionally, there are various aerosol products. Foam-like skin cleansing materials that form foam when discharged from an aerosol container are used as cleansing materials for the face, hands, body, scalp and hair. These foam-like skin cleansing materials are filled with an aerosol container with a stock solution and a propellant, and the stock solution contains a detergent composition, for example, an anionic surfactant. Petroleum gas (LPG) or the like is used.
フォーム状皮膚洗浄料では、泡のきめ細やかさが重視されており、特許文献1〜3には、アミノ酸系界面活性剤を含有し、噴射剤として液化石油ガスと炭酸ガスが併用されたエアゾール型皮膚洗浄料が開示されている。 In foam-like skin cleansers, emphasis is placed on the fineness of foam, and Patent Documents 1 to 3 contain an amino acid-based surfactant and an aerosol type in which liquefied petroleum gas and carbon dioxide are used in combination as propellants. A skin cleanser is disclosed.
しかしながら、顔等のデリケートな部位の洗浄料においては、泡質に対する要求が高く、より一層クリーミーな泡質が求められる。 However, in a delicate part such as a face, a demand for foam quality is high, and a more creamy foam quality is required.
本発明の課題は、クリーミーな泡を吐出することができるフォーム状皮膚洗浄料を提供することにある。 The subject of this invention is providing the foam-form skin cleansing agent which can discharge creamy foam.
本発明は、原液と噴射剤とがエアゾール容器に充填されたフォーム状皮膚洗浄料であって、前記原液が、
成分A:N−アシルグルタミン酸塩、
成分B:高級脂肪酸及び/又はその塩、
成分C:モノアルキルリン酸エステル塩、
成分D:ポリオキシエチレン硬化ヒマシ油、
成分E:多価アルコール、及び
成分F:水を45〜98質量%
を含有し、前記噴射剤が液化石油ガス及び炭酸ガスを含有する、フォーム状皮膚洗浄料に関する。
The present invention is a foam skin cleansing agent in which a stock solution and a propellant are filled in an aerosol container, the stock solution comprising:
Component A: N-acyl glutamate
Component B: higher fatty acid and / or salt thereof,
Component C: monoalkyl phosphate ester salt
Component D: polyoxyethylene hydrogenated castor oil,
Component E: Polyhydric alcohol, and Component F: 45 to 98% by mass of water
And the propellant contains a liquefied petroleum gas and a carbon dioxide gas.
本発明によれば、クリーミーな泡を吐出することができるフォーム状皮膚洗浄料を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, the foam-form skin cleansing agent which can discharge creamy foam can be provided.
本発明のフォーム状皮膚洗浄料は、原液と噴射剤とがエアゾール容器に充填されているものである。本発明のフォーム状皮膚洗浄料は、使用時、すなわちエアゾール容器から吐出される際に、及び/又は、対象に付着した後に、泡を形成するものであり、非常にクリーミーな泡を吐出することができる。以下、本発明のフォーム状皮膚洗浄料の各構成成分について説明する。 The foam skin cleansing material of the present invention is one in which a stock solution and a propellant are filled in an aerosol container. The foam skin cleansing material of the present invention forms foam when used, that is, when discharged from an aerosol container and / or after adhering to a target, and discharges very creamy foam. Can do. Hereinafter, each component of the foam skin cleansing material of the present invention will be described.
上記原液は、
成分A:N−アシルグルタミン酸塩
成分B:高級脂肪酸及び/又はその塩
成分C:モノアルキルリン酸エステル塩、
成分D:ポリオキシエチレン硬化ヒマシ油、
成分E:多価アルコール、及び
成分F:水
を必須成分として含有する。
上記原液は、上記必須成分に加えて、さらに、成分G:ポリグリセリン脂肪酸エステル及び/又は成分H:ポリエチレングリコール脂肪酸エステルを含有することが好ましい。
上記原液は、さらに上記成分A〜H以外の成分(その他の成分)を含有してもよい。成分A〜Hやその他の成分は、それぞれ、1種のみを用いてもよいし、2種以上を用いてもよい。
The stock solution is
Component A: N-acyl glutamate component B: higher fatty acid and / or salt thereof component C: monoalkyl phosphate ester salt
Component D: polyoxyethylene hydrogenated castor oil,
Component E: Polyhydric alcohol, and Component F: Water are contained as essential components.
In addition to the essential components, the stock solution preferably further contains component G: polyglycerin fatty acid ester and / or component H: polyethylene glycol fatty acid ester.
The stock solution may further contain components other than the components A to H (other components). Each of the components A to H and other components may be used alone or in combination of two or more.
成分AのN−アシルグルタミン酸塩は、洗浄力が高く、噴射剤に炭酸ガスが含まれていても良好な泡立ちを実現する。上記成分Aは、1種のみを用いてもよいし、2種以上を用いてもよい。 The N-acyl glutamate of component A has a high detergency and realizes good foaming even when carbon dioxide is contained in the propellant. Only 1 type may be used for the said component A, and 2 or more types may be used for it.
上記N−アシルグルタミン酸塩におけるアシル基としては、炭素数8〜24の直鎖又は分岐鎖の脂肪族アシル基等が挙げられる。具体的には、例えば、オクタノイル基、デカノイル基、ラウロイル基、ミリストイル基、パルミトイル基、ステアロイル基、イソステアロイル基、オレオイル基、リノレオイル基、ベヘニル基、ヤシ油脂肪酸由来のアシル基(以下、ヤシ油脂肪酸アシル基という)、パーム油脂肪酸由来のアシル基(以下、パーム脂肪酸アシル基という)等が挙げられる。 Examples of the acyl group in the N-acyl glutamate include linear or branched aliphatic acyl groups having 8 to 24 carbon atoms. Specifically, for example, octanoyl group, decanoyl group, lauroyl group, myristoyl group, palmitoyl group, stearoyl group, isostearoyl group, oleoyl group, linoleoyl group, behenyl group, acyl group derived from coconut oil fatty acid (hereinafter, coconut oil) Oil fatty acid acyl group), an acyl group derived from palm oil fatty acid (hereinafter referred to as palm fatty acid acyl group), and the like.
上記N−アシルグルタミン酸塩における塩としては、例えば、ナトリウム塩、カリウム塩等のアルカリ金属塩;モノエタノールアミン塩、ジエタノールアミン塩、トリエタノールアミン塩等のアルカノールアミン塩等が挙げられる。 Examples of the salt in the N-acyl glutamate include alkali metal salts such as sodium salt and potassium salt; alkanolamine salts such as monoethanolamine salt, diethanolamine salt and triethanolamine salt.
具体的な成分Aとしては、例えば、ラウロイルグルタミン酸ナトリウム、ラウロイルグルタミン酸カリウム、ラウロイルグルタミン酸トリエタノールアミン、ミリストイルグルタミン酸ナトリウム、ミリストイルグルタミン酸カリウム、ステアロイルグルタミン酸カリウム、ステアロイルグルタミン酸ナトリウム、ヤシ油脂肪酸アシルグルタミン酸ナトリウム(ココイルグルタミン酸ナトリウム)、ヤシ油脂肪酸アシルグルタミン酸カリウム(ココイルグルタミン酸カリウム)、ヤシ油脂肪酸アシルグルタミン酸トリエタノールアミン(ココイルグルタミン酸トリエタノールアミン)等が挙げられる。 Specific components A include, for example, sodium lauroyl glutamate, potassium lauroyl glutamate, triethanolamine lauroyl glutamate, sodium myristoyl glutamate, potassium myristoyl glutamate, potassium stearoyl glutamate, sodium stearoyl glutamate, sodium coconut fatty acid acyl glutamate (sodium cocoyl glutamate ), Coconut oil fatty acid acyl potassium glutamate (potassium cocoyl glutamate), coconut oil fatty acid acyl glutamic acid triethanolamine (cocoyl glutamic acid triethanolamine) and the like.
原液100質量%中の、成分Aの含有量は、洗浄力の観点、並びに良好な泡立ちを発揮させる観点から、好ましくは0.1〜20質量%、より好ましくは0.5〜15質量%、さらに好ましくは1〜10質量%である。上記含有量は、原液中に含まれる全ての成分Aの含有量の合計量である。 The content of component A in 100% by mass of the stock solution is preferably 0.1 to 20% by mass, more preferably 0.5 to 15% by mass, from the viewpoint of detergency, and from the viewpoint of exerting good foaming. More preferably, it is 1-10 mass%. The content is the total content of all components A contained in the stock solution.
成分Bは、高級脂肪酸及び/又はその塩、即ち、高級脂肪酸及び高級脂肪酸塩のうちのいずれか一方又は両方である。成分Bは、洗浄成分として作用するとともに、優れた起泡性及び泡もちを発揮する。上記成分Bは、1種のみを用いてもよいし、2種以上を用いてもよい。 Component B is a higher fatty acid and / or a salt thereof, that is, one or both of a higher fatty acid and a higher fatty acid salt. Ingredient B acts as a cleaning ingredient and exhibits excellent foaming properties and foaminess. Only 1 type may be used for the said component B, and 2 or more types may be used for it.
上記高級脂肪酸としては、例えば、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、ベヘニン酸等の炭素数12〜22の高級脂肪酸;オリーブ油、ヤシ油、パーム油、綿実油等の植物性油脂;魚油、牛脂等の動物性油脂等が挙げられる。中でも、優れた起泡性及び泡もちを発揮する観点、並びに洗浄力を高める観点から、炭素数12〜22の高級脂肪酸塩が好ましく、ラウリン酸、ミリスチン酸、パルミチン酸、及びステアリン酸がより好ましい。 Examples of the higher fatty acid include higher fatty acids having 12 to 22 carbon atoms such as lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, and behenic acid; vegetable oils such as olive oil, coconut oil, palm oil, and cottonseed oil Animal oils such as fish oil and beef tallow. Among these, from the viewpoint of exhibiting excellent foamability and foaminess, and from the viewpoint of enhancing detergency, higher fatty acid salts having 12 to 22 carbon atoms are preferable, and lauric acid, myristic acid, palmitic acid, and stearic acid are more preferable .
上記高級脂肪酸塩における塩としては、例えば、ナトリウム塩、カリウム塩等のアルカリ金属塩;モノエタノールアミン塩、ジエタノールアミン塩、トリエタノールアミン塩等のアルカノールアミン塩等が挙げられる。 Examples of the salt in the higher fatty acid salt include alkali metal salts such as sodium salt and potassium salt; alkanolamine salts such as monoethanolamine salt, diethanolamine salt and triethanolamine salt.
上記高級脂肪酸塩は、予め塩に調製された高級脂肪酸塩が配合されていてもよいし、高級脂肪酸と塩基とが原液中で塩を形成していてもよい。 The higher fatty acid salt may be mixed with a higher fatty acid salt prepared in advance, or the higher fatty acid and the base may form a salt in the stock solution.
原液100質量%中の、成分Bの含有量は、高級脂肪酸の量として、優れた起泡性及び泡もちを発揮する観点、並びに洗浄力を高める観点から、好ましくは0.01〜20質量%、より好ましくは0.05〜10質量%、さらに好ましくは0.07〜2質量%である。上記含有量は、原液中に含まれる全ての成分Bの含有量(高級脂肪酸として換算した場合の含有量)の合計量である。 The content of Component B in 100% by mass of the undiluted solution is preferably 0.01 to 20% by mass from the viewpoint of exhibiting excellent foamability and foaminess as well as enhancing detergency as the amount of higher fatty acid. More preferably, it is 0.05-10 mass%, More preferably, it is 0.07-2 mass%. The content is the total content of all components B contained in the stock solution (content when converted as a higher fatty acid).
成分Cのモノアルキルリン酸エステル塩は、洗浄成分として作用するとともに、泡の滑らかさを高め、クリーミーな泡質の泡を形成させるのに効果的である。上記成分Cは、1種のみを用いてもよいし、2種以上を用いてもよい。 The monoalkyl phosphate ester salt of Component C acts as a cleaning component and is effective in increasing foam smoothness and forming creamy foam. Only 1 type may be used for the said component C, and 2 or more types may be used for it.
上記モノアルキルリン酸エステル塩におけるアルキル基の炭素数は、泡質を向上させて滑らかな泡とする観点から、好ましくは8〜24、より好ましくは10〜20、さらに好ましくは12〜18である。 The number of carbon atoms of the alkyl group in the monoalkyl phosphate ester salt is preferably 8 to 24, more preferably 10 to 20, and still more preferably 12 to 18 from the viewpoint of improving foam quality to make smooth foam. .
上記モノアルキルリン酸エステル塩における塩としては、ナトリウム塩、カリウム塩等のアルカリ金属塩;モノエタノールアミン塩、ジエタノールアミン塩、トリエタノールアミン塩等のアルカノールアミン塩等が挙げられる。 Examples of the salt in the monoalkyl phosphate ester salt include alkali metal salts such as sodium salt and potassium salt; alkanolamine salts such as monoethanolamine salt, diethanolamine salt and triethanolamine salt.
具体的な成分Cとしては、例えば、ラウリルリン酸ナトリウム、ラウリルリン酸二ナトリウム、ラウリルリン酸カリウム、セチルリン酸カリウム、セチルリン酸ジエタノールアミン等が挙げられる。 Specific examples of component C include sodium lauryl phosphate, disodium lauryl phosphate, potassium lauryl phosphate, potassium cetyl phosphate, diethanolamine cetyl phosphate, and the like.
原液100質量%中の、成分Cの含有量は、泡質を向上させて滑らかな泡とする観点から、好ましくは0.01〜10質量%、より好ましくは0.05〜5質量%、さらに好ましくは0.1〜3質量%である。上記含有量は、原液中に含まれる全ての成分Cの含有量の合計量である。 The content of component C in 100% by mass of the stock solution is preferably 0.01 to 10% by mass, more preferably 0.05 to 5% by mass, and more preferably 0.05 to 5% by mass, from the viewpoint of improving the foam quality to obtain a smooth foam. Preferably it is 0.1-3 mass%. The content is the total content of all components C contained in the stock solution.
成分Dのポリオキシエチレン硬化ヒマシ油は、原液と噴射剤とのなじみを良好にし、きめ細やかな泡を形成させるのに効果的である。上記成分Dは、1種のみを用いてもよいし、2種以上を用いてもよい。 The polyoxyethylene hydrogenated castor oil of Component D is effective in improving the familiarity between the stock solution and the propellant and forming fine bubbles. Only 1 type may be used for the said component D, and 2 or more types may be used for it.
上記ポリオキシエチレン硬化ヒマシ油における酸化エチレンの平均付加モル数は、特に限定されないが、きめ細やかな泡を形成させる観点から、好ましくは10〜100、より好ましくは30〜60である。 The average number of added moles of ethylene oxide in the polyoxyethylene hydrogenated castor oil is not particularly limited, but is preferably 10 to 100, more preferably 30 to 60, from the viewpoint of forming fine bubbles.
原液100質量%中の、成分Dの含有量は、原液と噴射剤とのなじみを良好にし、きめ細やかな泡を形成させる観点から、好ましくは0.01〜5質量%、より好ましくは0.05〜3質量%、さらに好ましくは0.1〜1質量%である。上記含有量は、原液中に含まれる全ての成分Dの含有量の合計量である。 The content of component D in 100% by mass of the stock solution is preferably from 0.01 to 5% by mass, more preferably from the viewpoint of improving the familiarity between the stock solution and the propellant and forming fine bubbles. It is 05-3 mass%, More preferably, it is 0.1-1 mass%. The content is the total content of all components D contained in the stock solution.
成分Eの多価アルコールは、クリーミーな泡を持続させる、所謂、泡もちに効果的に作用するとともに、高級脂肪酸塩等の結晶の析出を抑制し、製剤安定性にも効果的に作用する。エアゾール製剤において塩等に起因する結晶の析出は、エアゾールの吐出口の目詰まりを引き起こす要因となり得るが、本発明においては、上記成分A〜成分Dとともに成分Eである多価アルコールを必須成分として配合することにより、塩等結晶の析出を抑制し、製剤安定性を高め、泡もちに優れたクリーミーな泡を吐出することができる。上記成分Eは、1種のみを用いてもよいし、2種以上を用いてもよい。 The polyhydric alcohol of component E effectively acts as a so-called foam that maintains creamy foam, suppresses the precipitation of crystals such as higher fatty acid salts, and effectively acts on the stability of the preparation. Precipitation of crystals due to salt or the like in an aerosol formulation can cause clogging of the discharge port of the aerosol, but in the present invention, polyhydric alcohol which is component E together with the above components A to D is an essential component. By blending, precipitation of crystals such as salts can be suppressed, formulation stability can be improved, and creamy foam with excellent foam can be discharged. The said component E may use only 1 type and may use 2 or more types.
具体的な成分Eとしては、例えば、エチレングリコール、ジエチレングリコール、トリエチレングリコール、プロピレングリコール、イソプレングリコール、ジプロピレングリコール、ポリエチレングリコール、1,3−ブチレングリコール(1,3−ブタンジオール)、1,2−ブタンジオール、1,2−ペンタンジオール、1,2−ヘキサンジオール、1,2−オクタンジオール、1,2−デカンジオール、グリセリン(1,2,3−プロパントリオール)、ジグリセリン、ポリグリセリン、ソルビトール、マルチトール、ポリオキシエチレンメチルグルコシド、ポリオキシプロピレンメチルグルコシド等が挙げられる。 Specific components E include, for example, ethylene glycol, diethylene glycol, triethylene glycol, propylene glycol, isoprene glycol, dipropylene glycol, polyethylene glycol, 1,3-butylene glycol (1,3-butanediol), 1,2 -Butanediol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol, glycerin (1,2,3-propanetriol), diglycerin, polyglycerin, Examples include sorbitol, maltitol, polyoxyethylene methyl glucoside, polyoxypropylene methyl glucoside and the like.
原液100質量%中の、成分Eの含有量は、泡もちを高める観点、並びに塩等の結晶の析出を抑制し、優れた製剤安定性を付与する観点から、好ましくは0.5〜40質量%、より好ましくは5〜35質量%、さらに好ましくは10〜30質量%である。上記含有量は、原液中に含まれる全ての成分Eの含有量の合計量である。 The content of component E in 100% by mass of the undiluted solution is preferably 0.5 to 40 masses from the viewpoint of enhancing foaminess and suppressing the precipitation of crystals such as salts and imparting excellent formulation stability. %, More preferably, it is 5-35 mass%, More preferably, it is 10-30 mass%. The content is the total content of all components E contained in the stock solution.
本発明において上記多価アルコールは、格段に優れた泡もちを実現させる観点、さらには格段に優れた製剤安定性を付与する観点から、ポリエチレングリコールを含有していることが好ましい。加えて、ポリエチレングリコールを含有させることにより、皮膚への刺激を低減させることも可能となる。 In the present invention, it is preferable that the polyhydric alcohol contains polyethylene glycol from the viewpoint of realizing extremely excellent foaminess and further from the viewpoint of imparting exceptionally excellent formulation stability. In addition, it is possible to reduce irritation to the skin by containing polyethylene glycol.
上記ポリエチレングリコールの数平均分子量は、所望の効果が十分に発揮されるのであれ特に限定されないが、泡もちの観点、並びに析出抑制の観点から、好ましくは50〜10000、より好ましくは100〜5000である。上記ポリエチレングリコールは、1種のみを用いてもよいし、数平均分子量の異なる2種以上を用いてもよい。 The number average molecular weight of the polyethylene glycol is not particularly limited as long as the desired effect is sufficiently exhibited, but from the viewpoint of foaminess and the suppression of precipitation, it is preferably 50 to 10,000, more preferably 100 to 5000. is there. Only 1 type may be used for the said polyethylene glycol, and 2 or more types from which a number average molecular weight differs may be used.
原液100質量%中の、上記ポリエチレングリコールの含有量は、泡もちを高める観点、並びに析出抑制効果を高める観点から、好ましくは0.1〜10質量%、より好ましくは0.5〜8質量%である。 The content of the polyethylene glycol in 100% by mass of the stock solution is preferably 0.1 to 10% by mass, more preferably 0.5 to 8% by mass, from the viewpoint of enhancing foaminess and the effect of suppressing precipitation. It is.
成分Fの水は、化粧品原料として使用できるものであれば特に限定されないが、通常、精製水が好ましく用いられる。 The water of component F is not particularly limited as long as it can be used as a cosmetic raw material, but usually purified water is preferably used.
原液100質量%中の、成分Fの水の含有量は、クリーミーな泡を形成する観点から、45〜98質量%であり、好ましくは50〜95質量%、より好ましくは55〜90質量%である。 The content of water of component F in 100% by mass of the stock solution is 45 to 98% by mass, preferably 50 to 95% by mass, more preferably 55 to 90% by mass, from the viewpoint of forming creamy foam. is there.
上記原液は、さらに、成分G:ポリグリセリン脂肪酸エステル及び/又は成分H:ポリエチレングリコール脂肪酸エステルを含有していることが好ましい。 The stock solution preferably further contains Component G: Polyglycerin fatty acid ester and / or Component H: Polyethylene glycol fatty acid ester.
成分Gのポリグリセリン脂肪酸エステルは、高級脂肪酸塩等の結晶の析出抑制を効果的に高めるだけでなく、皮膚への刺激をより低減させることも可能となる。上記成分Gは、1種のみを用いてもよいし、2種以上を用いてもよい。 The polyglycerin fatty acid ester of component G not only effectively increases the suppression of precipitation of crystals such as higher fatty acid salts, but also can reduce irritation to the skin. Only 1 type may be used for the said component G, and 2 or more types may be used for it.
具体的な成分Gとしては、例えば、モノステアリン酸ジグリセリル、モノオレイン酸ジグリセリル、モノイソステアリン酸ジグリセリル、モノステアリン酸テトラグリセリル、モノオレイン酸テトラグリセリル、モノラウリン酸ヘキサグリセリル、モノミリスチン酸ヘキサグリセリル、モノステアリン酸ヘキサグリセリル、モノオレイン酸ヘキサグリセリル、モノラウリン酸デカグリセリル、モノミリスチン酸デカグリセリル、モノステアリン酸デカグリセリル、モノオレイン酸デカグリセリル、モノリノール酸デカグリセリル等のポリグリセリン脂肪酸モノエステル;ジオレイン酸ジグリセリル、ジステアリン酸デカグリセリル、ジイソステアリン酸デカグリセリル等のポリグリセリン脂肪酸ジエステル;トリステアリン酸テトラグリセリル、トリステアリン酸ヘキサグリセリル、トリステアリン酸デカグリセリル、トリオレイン酸デカグリセリル等のポリグリセリン脂肪酸トリエステル;ペンタステアリン酸テトラグリセリル、ペンタオレイン酸テトラグリセリル、ペンタステアリン酸ヘキサグリセリル、ペンタオレイン酸ヘキサグリセリル等のポリグリセリン脂肪酸ペンタエステル等が挙げられる。中でも、結晶の析出抑制効果を高める観点、並びに皮膚刺激を低減させる観点から、ポリグリセリン脂肪酸モノエステルを用いることが好ましい。 Specific components G include, for example, diglyceryl monostearate, diglyceryl monooleate, diglyceryl monoisostearate, tetraglyceryl monostearate, tetraglyceryl monooleate, hexaglyceryl monolaurate, hexaglyceryl monomyristate Polyglycerin fatty acid monoesters such as hexaglyceryl monostearate, hexaglyceryl monooleate, decaglyceryl monolaurate, decaglyceryl monomyristate, decaglyceryl monostearate, decaglyceryl monooleate, decaglyceryl monolinoleate; Polyglycerin fatty acid diesters such as diglyceryl acid, decaglyceryl distearate, decaglyceryl diisostearate; tetraglyceryl tristearate , Polyglyceryl fatty acid triesters such as hexaglyceryl tristearate, decaglyceryl tristearate, decaglyceryl trioleate; tetraglyceryl pentastearate, tetraglyceryl pentaoleate, hexaglyceryl pentastearate, hexaglyceryl pentaoleate, etc. And polyglycerol fatty acid pentaesters. Among them, it is preferable to use polyglycerol fatty acid monoester from the viewpoint of enhancing the effect of suppressing the precipitation of crystals and reducing the skin irritation.
上記ポリグリセリン脂肪酸エステルにおけるポリグリセリンの平均重合度は、結晶の析出抑制効果を高める観点から、好ましくは2〜10、より好ましくは6〜10である。 The average degree of polymerization of polyglycerin in the polyglycerin fatty acid ester is preferably 2 to 10, more preferably 6 to 10 from the viewpoint of enhancing the effect of suppressing the precipitation of crystals.
また、上記ポリグリセリン脂肪酸エステルにおける脂肪酸は、結晶の析出抑制効果を高める観点から、炭素数が8〜24の脂肪酸が好ましく、より好ましくは炭素数が10〜20の脂肪酸、さらに好ましくは炭素数が12〜18の脂肪酸である。 In addition, the fatty acid in the polyglycerin fatty acid ester is preferably a fatty acid having 8 to 24 carbon atoms, more preferably a fatty acid having 10 to 20 carbon atoms, more preferably a carbon number, from the viewpoint of enhancing the effect of suppressing the precipitation of crystals. 12 to 18 fatty acids.
原液100質量%中の、成分Gの含有量は、結晶の析出抑制効果を高める観点、並びに皮膚刺激を低減させる観点から、好ましくは0.1〜10質量%、より好ましくは0.5〜7質量%、さらに好ましくは1〜5質量%である。上記含有量は、原液中に含まれる全ての成分Gの含有量の合計量である。 The content of component G in 100% by mass of the undiluted solution is preferably 0.1 to 10% by mass, more preferably 0.5 to 7%, from the viewpoint of enhancing the crystal precipitation suppression effect and reducing the skin irritation. It is 1 mass%, More preferably, it is 1-5 mass%. The above content is the total content of all components G contained in the stock solution.
成分Hのポリエチレングリコール脂肪酸エステルは、高級脂肪酸塩等の結晶の析出抑制を効果的に高めるだけでなく、泡もちを高めることも可能となる。上記成分Hは、1種のみを用いてもよいし、2種以上を用いてもよい。 The polyethylene glycol fatty acid ester of component H can not only effectively suppress the precipitation of crystals such as higher fatty acid salts, but also can increase foaminess. The said component H may use only 1 type and may use 2 or more types.
具体的な成分Hとしては、例えば、モノラウリン酸ポリエチレングリコール、モノステアリン酸ポリエチレングリコール、モノイソステアリン酸ポリエチレングリコール、モノオレイン酸ポリエチレングリコール等のモノ脂肪酸ポリエチレングリコール;ジラウリン酸ポリエチレングリコール、ジステアリン酸ポリエチレングリコール、ジイソステアリン酸ポリエチレングリコール、ジオレイン酸ポリエチレングリコール等のジ脂肪酸ポリエチレングリコール等が挙げられる。中でも、結晶の析出抑制効果を高める観点、並びに泡もちを高める観点から、モノ脂肪酸ポリエチレングリコールを用いることが好ましい。 Specific examples of the component H include monofatty acid polyethylene glycol such as polyethylene glycol monolaurate, polyethylene glycol monostearate, polyethylene glycol monoisostearate, polyethylene glycol monooleate; polyethylene glycol dilaurate, polyethylene glycol distearate, diisostearate. Examples include difatty acid polyethylene glycols such as polyethylene glycol acid and polyethylene glycol dioleate. Among these, monofatty acid polyethylene glycol is preferably used from the viewpoint of enhancing the effect of suppressing the precipitation of crystals and from the viewpoint of enhancing foaminess.
上記ポリエチレングリコール脂肪酸エステルにおける脂肪酸は、結晶の析出抑制効果を高める観点から、炭素数が8〜24の脂肪酸が好ましく、より好ましくは炭素数が10〜20の脂肪酸、さらに好ましくは炭素数が12〜18の脂肪酸である。 The fatty acid in the polyethylene glycol fatty acid ester is preferably a fatty acid having 8 to 24 carbon atoms, more preferably a fatty acid having 10 to 20 carbon atoms, more preferably 12 to 12 carbon atoms, from the viewpoint of enhancing the effect of suppressing the precipitation of crystals. 18 fatty acids.
また、上記ポリエチレングリコール脂肪酸エステルにおける酸化エチレンの平均付加モル数は、結晶の析出抑制効果を高める観点から、好ましくは100〜300、より好ましくは120〜280である。 Moreover, the average added mole number of ethylene oxide in the polyethylene glycol fatty acid ester is preferably 100 to 300, more preferably 120 to 280 from the viewpoint of enhancing the effect of suppressing the precipitation of crystals.
原液100質量%中の、成分Hの含有量は、結晶の析出抑制効果を高める観点、並びに泡もちを高める観点から、好ましくは0.01〜3質量%、より好ましくは0.1〜2.5質量%、さらに好ましくは0.3〜2質量%である。上記含有量は、原液中に含まれる全ての成分Hの含有量の合計量である。 The content of component H in 100% by mass of the stock solution is preferably from 0.01 to 3% by mass, more preferably from 0.1 to 2% from the viewpoint of enhancing the effect of suppressing the precipitation of crystals and increasing the foaminess. 5 mass%, More preferably, it is 0.3-2 mass%. The content is the total content of all components H contained in the stock solution.
原液は、特に限定されないが、例えば、上記成分A、成分B及び成分C以外のアニオン性界面活性剤、カチオン性界面活性剤、上記成分D、成分G及び成分H以外のノニオン性界面活性剤;香料;エタノール;シクロペンタシロキサン、ハイドロゲンジメチコン、カプリリルメチコン、ジメチコン等のシリコーン油;ミリスチン酸イソプロピル、パルミチン酸エチルヘキシル、2−エチルヘキサン酸セチル等の脂肪酸エステル油;フェノキシエタノール、オクトキシグリセリン、メチルパラベン等の防腐剤;メントール、メンチルグリセリルエーテル、カンファー、ペパーミント油等の冷感剤;グリチルリチン酸ジカリウム、グリチルリチン酸ステアリル等の抗炎症剤;シャクヤク、ボタンピ、ビワ、アロエ等の植物抽出エキス;カルボキシビニルポリマー、アルキル変性カルボキシビニルポリマー、ヒドロキシエチルセルロース、キサンタンガム等の増粘性高分子;トコフェロール、ジブチルヒドロキシトルエン等の酸化防止剤;アルブチン、アスコルビン酸等の美白剤;シリカ、タルク、ナイロンパウダー等の粉体等を含んでもよい。 The stock solution is not particularly limited. For example, anionic surfactants other than the above components A, B and C, a cationic surfactant, and a nonionic surfactant other than the above components D, G and H; Fragrance; ethanol; silicone oil such as cyclopentasiloxane, hydrogen dimethicone, caprylyl methicone, dimethicone; fatty acid ester oil such as isopropyl myristate, ethylhexyl palmitate, cetyl 2-ethylhexanoate; phenoxyethanol, octoxyglycerin, methylparaben, etc. Antiseptics; cooling agents such as menthol, menthyl glyceryl ether, camphor and peppermint oil; anti-inflammatory agents such as dipotassium glycyrrhizinate and stearyl glycyrrhizinate; plant extract extracts such as peonies, buttonpi, loquat and aloe; Thickening polymers such as nyl polymer, alkyl-modified carboxyvinyl polymer, hydroxyethyl cellulose, xanthan gum; antioxidants such as tocopherol and dibutylhydroxytoluene; whitening agents such as arbutin and ascorbic acid; powders such as silica, talc and nylon powder May be included.
上記原液は、常法により調製することができる。例えば、上記した各構成成分を混合し、公知の方法、具体的には、ホモミキサー等で撹拌する方法等が挙げられる。 The stock solution can be prepared by a conventional method. For example, the above-mentioned constituent components are mixed and a known method, specifically, a method of stirring with a homomixer or the like can be mentioned.
噴射剤は、液化石油ガス(LPG)と炭酸ガスを含有する。液化石油ガスに炭酸ガスを組み合わせることにより、より滑らかな泡質が得られる。 The propellant contains liquefied petroleum gas (LPG) and carbon dioxide. A smoother foam quality can be obtained by combining carbon dioxide with liquefied petroleum gas.
液化石油ガスとしては、プロパン、ブタン、イソブタン、イソペンタン等が挙げられ、通常、これらの混合ガスが汎用されているが、本発明では、皮膚への刺激が小さいことから、イソブタンが好ましい。 Examples of the liquefied petroleum gas include propane, butane, isobutane, isopentane and the like, and these mixed gases are generally used. However, in the present invention, isobutane is preferable because of less irritation to the skin.
液化石油ガス100体積%中の、イソブタンの含有量は、好ましくは80体積%以上、より好ましくは90体積%以上である。通常、液化石油ガス中のイソブタン量が多くなるほど、エアゾール容器の内圧が上がり難くなるが、本発明では、炭酸ガスの併用により、内圧を上げ、吐出の勢いを強くすることができる。 The content of isobutane in 100% by volume of liquefied petroleum gas is preferably 80% by volume or more, more preferably 90% by volume or more. Usually, as the amount of isobutane in the liquefied petroleum gas increases, the internal pressure of the aerosol container becomes more difficult to increase. However, in the present invention, the combined use of carbon dioxide gas can increase the internal pressure and increase the momentum of discharge.
原液と噴射剤の合計量100質量%中の、液化石油ガスの含有量は、好ましくは1〜10質量%、より好ましくは1〜8質量%である。 The content of the liquefied petroleum gas in the total amount of the stock solution and the propellant of 100% by mass is preferably 1-10% by mass, more preferably 1-8% by mass.
原液と噴射剤の合計量100質量%中の、炭酸ガスの含有量は、好ましくは0.1〜2質量%、より好ましくは0.1〜1.5質量%である。 The content of carbon dioxide in the total amount of the stock solution and the propellant is 100% by mass, preferably 0.1-2% by mass, more preferably 0.1-1.5% by mass.
他の噴射剤としては、特に限定されないが、例えば、空気、窒素、亜酸化窒素等のガス(特に、圧縮ガス);ジメチルエーテル(DME)、フロロカーボン等が挙げられる。 Although it does not specifically limit as another propellant, For example, gas (especially compressed gas), such as air, nitrogen, nitrous oxide; dimethyl ether (DME), a fluorocarbon, etc. are mentioned.
原液と噴射剤の合計量100質量%中の、噴射剤の含有量は、好ましくは1.1〜12質量%、より好ましくは1.1〜9.5質量%である。 The content of the propellant in the total amount of the stock solution and the propellant of 100% by mass is preferably 1.1 to 12% by mass, more preferably 1.1 to 9.5% by mass.
本発明のフォーム状皮膚洗浄料は、常法により、エアゾール容器に原液と噴射剤とを充填して、製造することができる。 The foam skin cleanser of the present invention can be produced by filling an aerosol container with a stock solution and a propellant by a conventional method.
本発明のフォーム状皮膚洗浄料は、顔等の皮膚を洗浄するために用いられる皮膚洗浄料である。本発明のフォーム状皮膚洗浄料としては、洗顔料、ハンドソープ、ボディソープや頭皮の洗浄料等が挙げられる。本発明のフォー状ム皮膚洗浄料は、クリーミーな泡質のものであるので、特に洗顔料等、デリケートな部位の洗浄料に適している。 The foam skin cleansing material of the present invention is a skin cleansing material used for cleaning skin such as the face. Examples of the foam skin cleanser of the present invention include face wash, hand soap, body soap and scalp cleanser. Since the foam skin cleansing material of the present invention has a creamy foam quality, it is particularly suitable for a delicate cleansing material such as a facial cleanser.
また、本発明のフォーム状皮膚洗浄料は、原液が、成分Eとしてポリエチレングリコールを含有し、さらに成分Gのポリグリセリン脂肪酸エステルを含有し、噴射剤がイソブタンを含有している態様において、皮膚への刺激性が格段に低下する。即ち、皮膚への低刺激性をより一層向上させる観点では、本発明のフォーム状皮膚洗浄料は成分Gを含有することが好ましく、さらに本発明のフォーム状皮膚洗浄料においては、成分Eがポリエチレングリコールを含有し、噴射剤がイソブタンを含有することが好ましい。かかるフォーム状皮膚洗浄料は、低刺激性フォーム状皮膚洗浄料としても有用である。 Further, the foam-like skin cleansing agent of the present invention has an aspect that the stock solution contains polyethylene glycol as component E, further contains the polyglycerin fatty acid ester of component G, and the propellant contains isobutane. The irritation of is significantly reduced. That is, from the viewpoint of further improving the low irritation to the skin, the foam skin cleanser of the present invention preferably contains Component G. In the foam skin cleanser of the present invention, Component E is polyethylene. It is preferred that it contains glycol and the propellant contains isobutane. Such a foam skin cleanser is also useful as a hypoallergenic foam skin cleanser.
以下に、本発明を実施例等に基づいてさらに詳細に説明するが、本発明はかかる実施例のみに限定されるものではない。 Hereinafter, the present invention will be described in more detail based on examples and the like, but the present invention is not limited only to such examples.
実施例1〜9及び比較例1〜2
表1に記した組成からなる原液をエアゾール容器(φ35mm×105mm、アルミ缶、容器満注量:91ml)に充填し、エアゾールバルブを該容器にクリンチした後、表1に記した組成からなる噴射剤をステムより充填し、適したスパウトを装着し、フォーム状皮膚洗浄料を得た。なお、エアゾール容器に充填した原液と噴射剤の合計量は50gである。
Examples 1-9 and Comparative Examples 1-2
After the stock solution having the composition shown in Table 1 is filled into an aerosol container (φ35 mm × 105 mm, aluminum can, full container amount: 91 ml), the aerosol valve is clinched into the container, and then sprayed with the composition described in Table 1 The agent was filled from the stem, a suitable spout was attached, and a foam skin cleanser was obtained. The total amount of the stock solution and the propellant filled in the aerosol container is 50 g.
実施例、比較例における各原料の詳細は次の通りである。なお、表1に記載の量は商品の量ではなく、各成分の量(有効成分の量)である。 Details of each raw material in Examples and Comparative Examples are as follows. In addition, the amount described in Table 1 is not the amount of merchandise but the amount of each component (amount of active ingredient).
ココイルグルタミン酸ナトリウム:アミノサーファクトACDS−L(旭化成ケミカルズ社製)
ミリスチン酸:EDENOR C14−99(Emery Oleochemicals社製)
ラウリルリン酸ナトリウム:NIKKOL SLP−N(日光ケミカルズ社製)
ポリオキシエチレン硬化ヒマシ油:EMALEX HC−50(日本エマルジョン社製:酸化エチレンの付加モル数50)
グリセリン:化粧用濃グリセリン(阪本薬品工業社製)
ポリエチレングリコール:PEG−1500(三洋化成工業社製:数平均分子量1500)
モノミリスチン酸デカグリセリル:グリサーフ 10MM(青木油脂工業社製)
モノステアリン酸ポリエチレングリコール:エマノーン3199VB(花王社製:酸化エチレンの付加モル数150)
キサンタンガム:エコーガムT(DSP五協フード&ケミカル社製)
Sodium cocoyl glutamate: Amino Surfact ACDS-L (Asahi Kasei Chemicals)
Myristic acid: EDENOR C14-99 (manufactured by Emery Oleochemicals)
Sodium lauryl phosphate: NIKKOL SLP-N (manufactured by Nikko Chemicals)
Polyoxyethylene hydrogenated castor oil: EMALEX HC-50 (manufactured by Nippon Emulsion Co., Ltd .: 50 moles of added ethylene oxide)
Glycerin: Concentrated glycerin for makeup (manufactured by Sakamoto Pharmaceutical Co., Ltd.)
Polyethylene glycol: PEG-1500 (manufactured by Sanyo Chemical Industries, Ltd .: number average molecular weight 1500)
Decaglyceryl monomyristate: Glysurf 10MM (Aoki Yushi Kogyo Co., Ltd.)
Polyethylene glycol monostearate: Emanon 3199VB (manufactured by Kao Corporation: 150 added moles of ethylene oxide)
Xanthan gum: Echo gum T (DSP Gokyo Food & Chemical Co., Ltd.)
実施例1〜9及び比較例1〜2で調製したフォーム状皮膚洗浄料について、以下の方法により、「泡質」及び「皮膚への刺激性」を評価した。結果を表1に示す。 The foam-like skin cleansing materials prepared in Examples 1 to 9 and Comparative Examples 1 and 2 were evaluated for “foam quality” and “skin irritation” by the following methods. The results are shown in Table 1.
〔試験例1:泡質の評価1(見た目)〕
各実施例及び各比較例のフォーム状皮膚洗浄料を手の平の上に吐出してもらい、吐出後の泡の「きめ細やかさ」について目視評価を行い、下記1点から4点の評価点に従ってスコア付けをした。
なお、評価は、評価パネル10名で行い、最も人数の多く得られた評価点(スコア)の結果を各試料の成績とした。
[Test Example 1: Evaluation of foam quality 1 (appearance)]
The foam-like skin cleansing material of each example and each comparative example was discharged on the palm of the hand, and a visual evaluation was performed on the “fineness” of the foam after the discharge, and the score according to the following 1 to 4 evaluation points I put it on.
In addition, evaluation was performed by 10 evaluation panels, and the result of the evaluation score (score) obtained with the largest number of people was used as the result of each sample.
〔評価点(スコア)基準〕
4点(評価点4:非常に良好):均一且つきめ細かな気泡により泡が形成されている
3点(評価点3:良好):不均一ではあるがきめ細かな気泡により泡が形成されている
2点(評価点2:不十分):大きな気泡が混在している泡が形成されている
1点(評価点1:不良):ガスが分離した状態で吐出されている
[Evaluation score (score) criteria]
4 points (evaluation point 4: very good): bubbles are formed by uniform and fine bubbles (evaluation point 3: good): bubbles are formed by non-uniform but fine bubbles 2 Point (evaluation point 2: inadequate): One point in which bubbles containing large bubbles are formed (evaluation point 1: poor): Gas is discharged in a separated state
〔試験例2:泡質の評価2(感触)〕
上記同評価パネルにより、40℃の温水で顔を洗い流してもらった後、各実施例及び各比較例のフォーム状皮膚洗浄料を用いて実際に洗顔操作を行ってもらい、頬部に泡をあて、円を描くように延び広げた時の感触(肌あたり感)について官能評価を行い、下記1点から4点の評価点に従ってスコア付けをした。
なお、評価は、試験例1と同様に最も人数の多く得られた評価点(スコア)の結果を各試料の成績とした。
[Test Example 2: Foam quality evaluation 2 (feel)]
After having the face washed off with warm water of 40 ° C. by the same evaluation panel, the face-cleaning operation was actually performed using the foam skin cleansing material of each Example and each Comparative Example, and foam was applied to the cheek. The sensory evaluation was performed on the feel (feel per skin) when extending and spreading like a circle, and scored according to the following 1 to 4 evaluation points.
In the evaluation, the results of evaluation points (scores) obtained with the largest number of people were used as the results of each sample as in Test Example 1.
〔評価点(スコア)基準〕
4点(評価点4:非常に良好):クリーミーな泡感(滑らかな感触)が非常に高い
3点(評価点3:良好):クリーミーな泡感(滑らかな感触)がある
2点(評価点2:不十分):クリーミーな泡感(滑らかな感触)に劣る
1点(評価点1:不良):クリーミーな泡感(滑らかな感触)が全くない
[Evaluation score (score) criteria]
4 points (evaluation point 4: very good): 3 points with very high creamy foam feeling (smooth touch) (evaluation point 3: good): 2 points with creamy foam feeling (smooth touch) (evaluation) Point 2: insufficient): 1 point inferior to creamy foam feeling (smooth touch) (evaluation point 1: poor): no creamy foam feeling (smooth touch)
〔試験例3:皮膚への刺激性の評価〕
上記同評価パネルにより、40℃の温水で顔を洗い流してもらった後、各実施例及び各比較例のフォーム状皮膚洗浄料を用いて実際に顔全体の洗顔を行ってもらい、洗浄中の「灼熱感」「チクチク感」「ヒリヒリ感」などの「皮膚への刺激」の有無について官能評価を行い、下記1点から5点の5段階に区分した評価点に従ってスコア付けをした。
なお、評価は、最も人数の多く得られた評価点(スコア)の結果を各試料の成績とした。
[Test Example 3: Evaluation of skin irritation]
After having the face washed away with warm water of 40 ° C. by the same evaluation panel, the face was actually washed using the foam skin cleanser of each Example and each Comparative Example. The sensory evaluation was performed for the presence or absence of “skin irritation” such as “burning sensation”, “tingling sensation”, “burning sensation”, and scored according to the evaluation points divided into 5 levels from 1 point to 5 points below.
In addition, evaluation made the result of the evaluation score (score) obtained with the largest number of people the result of each sample.
〔評価点(スコア)基準〕
5点(評価点5):皮膚刺激を感じない(皮膚刺激が低い)
4点(評価点4):皮膚刺激を僅かに感じる
3点(評価点3):皮膚刺激を感じる
2点(評価点2):皮膚刺激を強く感じる
1点(評価点1):皮膚刺激を非常に強く感じる(皮膚刺激が高い)
[Evaluation score (score) criteria]
5 points (evaluation point 5): no skin irritation (skin irritation is low)
4 points (evaluation point 4): 3 points for slightly feeling skin irritation (evaluation point 3): 2 points for feeling skin irritation (evaluation point 2): 1 point for strongly feeling skin irritation (evaluation point 1): Skin irritation Feels very strong (high skin irritation)
以上の結果より、実施例1〜9のフォーム状皮膚洗浄料は、比較例1〜2のものと対比して、クリーミーな泡を吐出することができることが分かる。
なかでも、実施例1〜3、比較例1の対比から、N−アシルグルタミン酸塩の配合により、クリーミーな泡感が向上することが分かる。
同様に、実施例1、4、5の対比、実施例1、8、9、比較例2の対比から、高級脂肪酸及び多価アルコールの配合により、クリーミーな泡感が向上することが分かる。
また、実施例1、6、7の対比から、モノアルキルリン酸エステル塩の配合により、泡のきめ細かさとクリーミーな泡感のいずれもが向上することが分かる。
From the above results, it can be seen that the foam-like skin cleansing materials of Examples 1 to 9 can discharge creamy foam as compared with those of Comparative Examples 1 and 2.
Especially, it turns out that creamy foam feeling improves by the mixing | blending of N-acyl glutamate from the comparison of Examples 1-3 and the comparative example 1. FIG.
Similarly, from the comparison of Examples 1, 4, 5 and the comparison of Examples 1, 8, 9 and Comparative Example 2, it can be seen that the creamy foam feeling is improved by blending of higher fatty acid and polyhydric alcohol.
Moreover, it turns out that both fineness of a foam and creamy foam feeling improve by the mixing | blending of the monoalkyl phosphate ester salt from the contrast of Example 1, 6, 7.
本発明のフォーム状皮膚洗浄料は、顔、手、身体、頭皮や毛髪用の洗浄料等に使用することができる。 The foam-like skin cleansing material of the present invention can be used as a cleansing material for the face, hands, body, scalp and hair.
Claims (3)
成分A:N−アシルグルタミン酸塩、
成分B:高級脂肪酸及び/又はその塩、
成分C:モノアルキルリン酸エステル塩、
成分D:ポリオキシエチレン硬化ヒマシ油、
成分E:多価アルコール、及び
成分F:水を45〜98質量%
を含有し、前記噴射剤が液化石油ガス及び炭酸ガスを含有する、フォーム状皮膚洗浄料。 A foam-like skin cleansing agent in which a stock solution and a propellant are filled in an aerosol container, wherein the stock solution is
Component A: N-acyl glutamate
Component B: higher fatty acid and / or salt thereof,
Component C: monoalkyl phosphate ester salt
Component D: polyoxyethylene hydrogenated castor oil,
Component E: Polyhydric alcohol, and Component F: 45 to 98% by mass of water
A foam-like skin cleanser, wherein the propellant contains liquefied petroleum gas and carbon dioxide.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015228932A JP6795297B2 (en) | 2015-11-24 | 2015-11-24 | Foam skin cleanser |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015228932A JP6795297B2 (en) | 2015-11-24 | 2015-11-24 | Foam skin cleanser |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017095393A true JP2017095393A (en) | 2017-06-01 |
JP6795297B2 JP6795297B2 (en) | 2020-12-02 |
Family
ID=58816723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015228932A Active JP6795297B2 (en) | 2015-11-24 | 2015-11-24 | Foam skin cleanser |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6795297B2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019059392A1 (en) * | 2017-09-25 | 2019-03-28 | 株式会社マンダム | Foamy skin cleanser |
JP2019059677A (en) * | 2017-09-25 | 2019-04-18 | 株式会社マンダム | Foamy skin cleanser |
JP2019059720A (en) * | 2017-09-25 | 2019-04-18 | 株式会社マンダム | Foamy skin cleanser |
JP2019059721A (en) * | 2017-09-25 | 2019-04-18 | 株式会社マンダム | Foamy skin cleanser |
JP2019199407A (en) * | 2018-05-15 | 2019-11-21 | 東洋エアゾール工業株式会社 | Foam-forming aerosol composition |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61287997A (en) * | 1985-06-14 | 1986-12-18 | 株式会社資生堂 | Aerosol composition |
JPS61291700A (en) * | 1985-06-18 | 1986-12-22 | ライオン株式会社 | Foamable skin cleaning composition |
JP2004292584A (en) * | 2003-03-26 | 2004-10-21 | Shiseido Co Ltd | Foamed aerosol detergent composition |
JP2011207862A (en) * | 2010-03-29 | 2011-10-20 | Nisshin Kagaku Kk | Foamy facial wash composition |
JP2012240985A (en) * | 2011-05-23 | 2012-12-10 | Kao Corp | Aerosol type skin cleanser |
JP2014129307A (en) * | 2012-12-28 | 2014-07-10 | Kao Corp | Aerosol cosmetic |
-
2015
- 2015-11-24 JP JP2015228932A patent/JP6795297B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61287997A (en) * | 1985-06-14 | 1986-12-18 | 株式会社資生堂 | Aerosol composition |
JPS61291700A (en) * | 1985-06-18 | 1986-12-22 | ライオン株式会社 | Foamable skin cleaning composition |
JP2004292584A (en) * | 2003-03-26 | 2004-10-21 | Shiseido Co Ltd | Foamed aerosol detergent composition |
JP2011207862A (en) * | 2010-03-29 | 2011-10-20 | Nisshin Kagaku Kk | Foamy facial wash composition |
JP2012240985A (en) * | 2011-05-23 | 2012-12-10 | Kao Corp | Aerosol type skin cleanser |
JP2014129307A (en) * | 2012-12-28 | 2014-07-10 | Kao Corp | Aerosol cosmetic |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019059392A1 (en) * | 2017-09-25 | 2019-03-28 | 株式会社マンダム | Foamy skin cleanser |
JP2019059677A (en) * | 2017-09-25 | 2019-04-18 | 株式会社マンダム | Foamy skin cleanser |
JP2019059720A (en) * | 2017-09-25 | 2019-04-18 | 株式会社マンダム | Foamy skin cleanser |
JP2019059721A (en) * | 2017-09-25 | 2019-04-18 | 株式会社マンダム | Foamy skin cleanser |
CN110612094A (en) * | 2017-09-25 | 2019-12-24 | 株式会社漫丹 | Foam-like skin cleaning material |
JP7121617B2 (en) | 2017-09-25 | 2022-08-18 | 株式会社マンダム | foam skin cleanser |
JP7121476B2 (en) | 2017-09-25 | 2022-08-18 | 株式会社マンダム | foam skin cleanser |
JP7121618B2 (en) | 2017-09-25 | 2022-08-18 | 株式会社マンダム | foam skin cleanser |
JP2019199407A (en) * | 2018-05-15 | 2019-11-21 | 東洋エアゾール工業株式会社 | Foam-forming aerosol composition |
JP7120803B2 (en) | 2018-05-15 | 2022-08-17 | 東洋エアゾール工業株式会社 | Foam forming aerosol composition |
Also Published As
Publication number | Publication date |
---|---|
JP6795297B2 (en) | 2020-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6645814B2 (en) | Foam skin cleanser | |
JP6862069B2 (en) | Foam skin cleanser | |
JP6795297B2 (en) | Foam skin cleanser | |
JP6571361B2 (en) | Foam skin cleanser | |
JP5707225B2 (en) | Aerosol skin cleanser | |
JPH1135972A (en) | Liquid lotion composition for filling in foaming vessel | |
JP6738141B2 (en) | Aerosol cosmetics | |
JP7501373B2 (en) | Low viscosity liquid cleaner | |
JP2001181609A (en) | Aerosol composition | |
WO2019059392A1 (en) | Foamy skin cleanser | |
JP7121617B2 (en) | foam skin cleanser | |
JP7121618B2 (en) | foam skin cleanser | |
JP5707226B2 (en) | Aerosol skin cleanser | |
JP7247710B2 (en) | personal care composition | |
KR102352025B1 (en) | Body cleansing composition | |
JP7121476B2 (en) | foam skin cleanser | |
JP2019172624A (en) | Skin detergent | |
JP2023045805A (en) | Foamy skin cleanser | |
JP7356155B2 (en) | Foamy aerosol warming skin cleansing composition | |
JP7427486B2 (en) | foam skin cleanser | |
JP2010163385A (en) | Composition for foam detergent and foam detergent | |
JP2001316218A (en) | Cosmetic and aerosol type cosmetic | |
JP2024064854A (en) | Foamy skin cleanser | |
JP2023098060A (en) | Foamable aerosol composition and aerosol product | |
WO2023145908A1 (en) | Two-layer-separated cleansing agent composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180622 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190509 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190605 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190724 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200107 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200203 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20200602 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200831 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20200831 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200923 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20200925 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20200928 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20201111 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20201112 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6795297 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |